Finanzwire Finanzwire
Basculer en Français
9637 Companies
191664 Keywords
123055 Articles
102104 Press releases
Headlines Articles Press releases Ovation Science Inc. Remove
  1. Home
  2. Companies
  3. Ovation Science Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/11/2024 at 15:40, 1 year 9 months ago

    Ovation Science Expands Market Reach with Exclusive Canadian License Agreement

    Ovation Science Inc. Ripco Processing Canada Cannabis Market Invisicare Technology Cannabis Licensing Agreement
  • PRESS RELEASE

    published on 04/11/2024 at 15:35, 1 year 9 months ago

    Ovation Science Expands Market Reach with Exclusive Canadian License Agreement

    Ovation Science Inc. signs exclusive licensing agreement with Ripco for its topical cannabis products in Canada, expanding market presence with Invisicare® technology
    Ovation Science Inc. Ripco Processing Inc. Topical Cannabis Products Exclusive Licensing Agreement Invisicare
    Logo of Ovation Science Inc.
Previous page
1 2
Accesswire
  • Published on 01/12/2026 at 15:00, 1 hour 4 minutes ago

    Sky Gold Corp. Assigns Shebandowan Star Lake Option to Gold X2

  • Published on 01/12/2026 at 15:00, 1 hour 4 minutes ago

    PPX Mining Provides Construction Progress Update on Gold and Silver Processing Plant

  • Published on 01/12/2026 at 15:00, 1 hour 4 minutes ago

    Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

  • Published on 01/12/2026 at 14:40, 1 hour 24 minutes ago

    NextSource Materials Executes Term Sheets with Strategic Investors and Local Capital Partners to Advance Towards Final Investment Decision for its Proposed UAE Battery Anode Facility

  • Published on 01/12/2026 at 14:05, 1 hour 59 minutes ago

    Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target

View all ACCESSWIRE
EQS Group
  • Published on 01/12/2026 at 15:34, 30 minutes ago

    Supervisory Board extends term of Chief Financial Officer Christian Harm

  • Published on 01/12/2026 at 15:24, 40 minutes ago

    PIERER MOBILITY AG (to be renamed soon to Bajaj Mobility AG): KTM AG expands Executive Board

  • Published on 01/12/2026 at 15:00, 1 hour 4 minutes ago

    Oriental Culture Holding LTD Announces Special Cash Dividend Plan to Reward Shareholders on Fifth Anniversary of Listing

  • Published on 01/12/2026 at 15:00, 1 hour 4 minutes ago

    Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity

  • Published on 01/12/2026 at 14:56, 1 hour 8 minutes ago

    Blue Elephant Energy acquires 381 MW wind portfolio in Mecklenburg-Western Pomerania and increases its own wind portfolio by three and a half times to 533 MW

View all EQS
Les Echos
  • Published on 01/12/2026 at 09:00, 7 hours 4 minutes ago

    Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum

  • Published on 01/09/2026 at 18:30, 2 days 21 hours ago

    H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm

  • Published on 01/09/2026 at 17:45, 2 days 22 hours ago

    January 2026

  • Published on 01/09/2026 at 17:45, 2 days 22 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 01/09/2026 at 17:42, 2 days 22 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy